Spark Therapeutics

Galien Forum USA 2024 / PANEL 6A - mRNA VS. GENE THERAPYПодробнее

The Medical Material Review Process at Spark TherapeuticsПодробнее

Creating Collaboration within Medical ExcellenceПодробнее

4. The Journey of Building Medical Operations with Michael Kahn of Spark TherapeuticsПодробнее

Gene Therapy For IRD’sПодробнее

NEJM Interview: Dr. Katherine A. High on gene therapy for genetic disease.Подробнее

Synthetic biology approaches to improve cell therapy functionПодробнее

Michael Kahn I Spark Therapeutics Leadership in Medical AffairsПодробнее

Revolutionizing Health with Gene Therapy!#future #startups #ai #genetherapy #healthtech #innovationПодробнее

Streamlining Processes in Medical AffairsПодробнее

Hemophilia AAV Gene Therapy AnimationПодробнее

世界上最昂贵的药品 - Luxturna / 每年85万美元 / 制造商 - Spark Therapeutics, Inc. /治疗 双等位基因RPE65突变/医疗/医药/DNA/药物Подробнее

525: Developing Gene Therapies for Rare Inherited Retinal Diseases - Dr. Daniel ChungПодробнее

From Molecules to Medicine: Pathways in Pharmaceutics and TherapeuticsПодробнее

CombiGenes vd om avtalet med Spark TherapeuticsПодробнее

Spark Therapeutics Webinar- Trial ExpectationsПодробнее

HYBRID 2024: MARIA GRAZIA BIFERIПодробнее

Lift Up Journeys - Episode 15 - Snehal Naik, Head of Regulatory at Spark TherapeuticsПодробнее

Let's Chat About...Bespoke Gene Therapy ConsortiumПодробнее

世界上最昂贵的药品 / Pharmaceutical Drug - Luxturna /制造商 - Spark Therapeutics, Inc. / 用途 - 治疗 双等位基因RPE65突变Подробнее